Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Tissue Engineering. Part B, Reviews
|
December 11, 2012
The regulatory imperative: international perspective
Tim Bertram, Kiki B Hellman, Yves Bayon, et al.
Blood Purification
|
March 1, 2021
Protocol and Baseline Data on Renal Autologous Cell Therapy Injection in Adults with Chronic Kidney Disease Secondary to Congenital Anomalies of the Kidney and Urinary Tract
Joseph Stavas, Maria Diaz-Gonzalez de Ferris, Ashley Johns, et al.
Kidney International Reports
|
November 17, 2017
Implantation of Autologous Selected Renal Cells in Diabetic Chronic Kidney Disease Stages 3 and 4-Clinical Experience of a "First in Human" Study
Peter Stenvinkel, Jonas Wadström, Tim Bertram, et al.
Tissue Engineering. Part A
|
September 25, 2013
Bench to business: a framework to assess technology readiness
Maria B Rahmany, Bill J Tawil, Kiki B Hellman, et al.
Tissue Engineering. Part B, Reviews
|
October 25, 2016
How Regenerative Medicine Stakeholders Adapt to Ever-Changing Technology and Regulatory Challenges? Snapshots from the World TERMIS Industry Symposium (September 10, 2015, Boston)
Yves Bayon, Mark Van Dyke, Robert Buelher, et al.
Kidney International Reports
|
March 27, 2026
Corrigendum to "Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis" [<i>Kidney International Reports</i> Volume 7, Issue 7, July 2022, Pages 1619-1629]
Joseph Stavas, Guido Filler, Deepak Jain, et al.
Kidney International Reports
|
July 11, 2022
Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis
Joseph Stavas, Guido Filler, Deepak Jain, et al.
American Journal of Nephrology
|
January 16, 2022
Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design
Joseph Stavas, David Gerber, Steven G Coca, et al.
Cell Transplantation
|
August 15, 2012
A population of selected renal cells augments renal function and extends survival in the ZSF1 model of progressive diabetic nephropathy
Rusty Kelley, Andrew Bruce, Tom Spencer, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Tissue Engineering. Part B, Reviews
|
December 11, 2012
The regulatory imperative: international perspective
Tim Bertram, Kiki B Hellman, Yves Bayon, et al.
Blood Purification
|
March 1, 2021
Protocol and Baseline Data on Renal Autologous Cell Therapy Injection in Adults with Chronic Kidney Disease Secondary to Congenital Anomalies of the Kidney and Urinary Tract
Joseph Stavas, Maria Diaz-Gonzalez de Ferris, Ashley Johns, et al.
Kidney International Reports
|
November 17, 2017
Implantation of Autologous Selected Renal Cells in Diabetic Chronic Kidney Disease Stages 3 and 4-Clinical Experience of a "First in Human" Study
Peter Stenvinkel, Jonas Wadström, Tim Bertram, et al.
Tissue Engineering. Part A
|
September 25, 2013
Bench to business: a framework to assess technology readiness
Maria B Rahmany, Bill J Tawil, Kiki B Hellman, et al.
Tissue Engineering. Part B, Reviews
|
October 25, 2016
How Regenerative Medicine Stakeholders Adapt to Ever-Changing Technology and Regulatory Challenges? Snapshots from the World TERMIS Industry Symposium (September 10, 2015, Boston)
Yves Bayon, Mark Van Dyke, Robert Buelher, et al.
Kidney International Reports
|
March 27, 2026
Corrigendum to "Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis" [<i>Kidney International Reports</i> Volume 7, Issue 7, July 2022, Pages 1619-1629]
Joseph Stavas, Guido Filler, Deepak Jain, et al.
Kidney International Reports
|
July 11, 2022
Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis
Joseph Stavas, Guido Filler, Deepak Jain, et al.
American Journal of Nephrology
|
January 16, 2022
Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design
Joseph Stavas, David Gerber, Steven G Coca, et al.
Cell Transplantation
|
August 15, 2012
A population of selected renal cells augments renal function and extends survival in the ZSF1 model of progressive diabetic nephropathy
Rusty Kelley, Andrew Bruce, Tom Spencer, et al.
Page
of 1